Hosted on MSN
How a scrappy biotech startup backed by Microsoft’s co-founders set the stage for two Nobel winners
The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten Seattle-area biotech startup that was backed by Microsoft’s co-founders. Darwin ...
Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only covalent Werner helicase (WRN) inhibitor to have made it into the clinic. Vividion and Roche have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback